» Articles » PMID: 25651937

Mechanisms of Airway Hyper-responsiveness in Asthma: the Past, Present and Yet to Come

Overview
Date 2015 Feb 6
PMID 25651937
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Airway hyper-responsiveness (AHR) has long been considered a cardinal feature of asthma. The development of the measurement of AHR 40 years ago initiated many important contributions to our understanding of asthma and other airway diseases. However, our understanding of AHR in asthma remains complicated by the multitude of potential underlying mechanisms which in reality are likely to have different contributions amongst individual patients. Therefore, the present review will discuss the current state of understanding of the major mechanisms proposed to contribute to AHR and highlight the way in which AHR testing is beginning to highlight distinct abnormalities associated with clinically relevant patient populations. In doing so we aim to provide a foundation by which future research can begin to ascribe certain mechanisms to specific patterns of bronchoconstriction and subsequently match phenotypes of bronchoconstriction with clinical phenotypes. We believe that this approach is not only within our grasp but will lead to improved mechanistic understanding of asthma phenotypes and we hoped to better inform the development of phenotype-targeted therapy.

Citing Articles

Eosinophil-Driven vs. Eosinophil-Associated Severe Asthma: Practical Implications for Target Treatment.

DAiuto V, Mormile I, Granata F, Romano A, Della Casa F, Mignogna G Int J Mol Sci. 2025; 26(4).

PMID: 40004192 PMC: 11855446. DOI: 10.3390/ijms26041729.


Possible Involvement of Lysophospholipids in Severe Asthma as Novel Lipid Mediators.

Kume H, Kazama K, Sato R, Sato Y Biomolecules. 2025; 15(2).

PMID: 40001485 PMC: 11852450. DOI: 10.3390/biom15020182.


Isoprenaline-Modified Polyethyleneimine as an Efficient Gene Delivery System for Targeted Asthma Therapy and Airway Remodeling Inhibition.

An J, Choi M, Kim S, Yoon H, Jang A, Lee S Biomater Res. 2025; 29:0136.

PMID: 39896757 PMC: 11782793. DOI: 10.34133/bmr.0136.


Diagnostic value of lung function tests in long COVID: analysis of positive bronchial provocation test outcomes.

Liu W, Feng Q, Yuan X, Lu C, Wang S, Yuan Y Front Med (Lausanne). 2025; 11():1512658.

PMID: 39830383 PMC: 11738905. DOI: 10.3389/fmed.2024.1512658.


Dissecting SNARE-Mediated Exocytosis in RBL-2H3 Mast Cells.

Adhikari P, Xu H Methods Mol Biol. 2025; 2887():149-166.

PMID: 39806152 DOI: 10.1007/978-1-0716-4314-3_10.


References
1.
John A, Zhu Y, Brightling C, Pang L, Knox A . Human airway smooth muscle cells from asthmatic individuals have CXCL8 hypersecretion due to increased NF-kappa B p65, C/EBP beta, and RNA polymerase II binding to the CXCL8 promoter. J Immunol. 2009; 183(7):4682-92. PMC: 3992371. DOI: 10.4049/jimmunol.0803832. View

2.
GIBBONS W, Sharma A, Lougheed D, Macklem P . Detection of excessive bronchoconstriction in asthma. Am J Respir Crit Care Med. 1996; 153(2):582-9. DOI: 10.1164/ajrccm.153.2.8564102. View

3.
Davis B, Cockcroft D . Past, present and future uses of methacholine testing. Expert Rev Respir Med. 2012; 6(3):321-9. DOI: 10.1586/ers.12.29. View

4.
Simpson J, Scott R, Boyle M, Gibson P . Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006; 11(1):54-61. DOI: 10.1111/j.1440-1843.2006.00784.x. View

5.
Agrawal A, Rengarajan S, Adler K, Ram A, Ghosh B, Fahim M . Inhibition of mucin secretion with MARCKS-related peptide improves airway obstruction in a mouse model of asthma. J Appl Physiol (1985). 2006; 102(1):399-405. DOI: 10.1152/japplphysiol.00630.2006. View